A Case Report of Papulo-pustular Rosacea-Like Reaction after the Second Dose of Pfizer Vaccine | ||
Iraqi Postgraduate Medical Journal | ||
Article 18, Volume 21, Issue 1, January 2022, Pages 127-130 PDF (186.65 K) | ||
Document Type: Case Report | ||
DOI: 10.52573/ipmj.2021.174081 | ||
Authors | ||
Hayder Al-Hamamy1; Zainab K Jawad2 | ||
1Iraqi Board for Medical Specializations | ||
2Baghdad Teaching Hospital, Medical City, Baghdad, Iraq | ||
Abstract | ||
Coronavirus disease-2019 (COVID-19) has affected countries around the world. The introduction of COVID-19 vaccines has proved the most effective weapon in the fight against the disease. The massive vaccination campaign against COVID-19 pandemic started in 2020 lead to significant decrease in the number of symptomatic infected patients and a decline in the mortality related to COVID-19 infection. However, with the vaccination of billions of people, data on vaccine-induced adverse reactions are also emerging. Here we report a 50 year old woman who manifested a papule-pustular rash within 24hours of receiving the second dose of pfizerBioNTech COVID19 vaccine. We report this case to raise awareness regarding various cutaneous manifestations associated with COVID-19 vaccination. | ||
References | ||
10. Hayran Y, Lay I, Mocan MC, Bozduman T, Ersoy-Evans S. Vascular endothelial growth factor gene polymorphisms in patients with rosacea: A case-control study. J Am Acad Dermatol 2019; 81: 348– 354.CrossrefCASPubMedWeb of Science®Google Scholar
11. Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 vaccines and the skin. The landscape of cutaneous vaccine reactions worldwide. Dermatol Clin. 2021;39:653-73. [CrossRef] [PubMed] [Google Scholar]
12. Henry D, Henry D. Herpes zoster following ChAdOx1 nCoV-19 corona virus vaccine (recombinant): A case report. J Skin Sex Transm Dis 1-3. [CrossRef] [Google Scholar] | ||
Statistics Article View: 80 PDF Download: 353 |